DKS Co. Ltd.

4461

JP3475000000

Commodity Chemicals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-06-14 EDT			5-day change	1st Jan Change
3,800 ^JPY	+4.40%		-3.06%	+93.78%

06-04	DKS Swings to Fiscal-Year Attributable Profit on Extraordinary Items, Lifts Year-End Dividend	MT
2023	DKS Co. Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 6, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	CI

DKS Co. Ltd. acquired Biococoon Laboratories, Inc. and Ikeda Yakusou Co., Ltd.

September 12, 2018

DKS Co. Ltd. (TSE:4461) acquired Biococoon Laboratories, Inc. and Ikeda Yakusou Co., Ltd. recently. Upon completion, Biococoon Laboratories, Inc. and Ikeda Yakusou Co., Ltd. became wholly-owned subsidiaries of DKS Co. Ltd.

Latest news about DKS Co. Ltd.

DKS Swings to Fiscal-Year Attributable Profit on Extraordinary Items, Lifts Year-End Dividend	06-03	MT
DKS Co. Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 6, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	11-15	CI
DKS Co. Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	11-15	CI
DKS Co. Ltd. Provides Dividend Guidance for the Second Quarter-End and Fiscal Year-End of the Fiscal Year Ending March 31, 2024	23-08-10	CI
DKS Co. Ltd. Provides Consolidated Earnings Guidance for the Half Year and Full Year of the Fiscal Year Ending March 31, 2024	23-08-10	CI
Dks Co. Ltd. Provides Consolidated Earnings Guidance for the Half Year and Full Year of Fiscal Year Ending March 31, 2024	23-06-05	CI
Dks Co. Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	23-06-05	CI
DKS Co. Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI
DKS Co. Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023	23-02-10	CI
DKS Co. Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023	23-02-10	CI
DKS Co. Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2023	22-11-14	CI
DKS Co. Ltd. Declares Dividend for the Second Quarter Fiscal Year Ended March 31, 2023, Payable on December 6, 2022	22-11-14	CI
Dks Co. Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2023	22-11-14	CI
Tranche Update on DKS Co. Ltd.'s Equity Buyback Plan announced on June 24, 2022.	22-08-22	CI
DKS Co. Ltd.'s Equity Buyback announced on June 24, 2022, has closed with 641,700 shares, representing 6.3% for ¥1,499.96 million.	22-08-21	CI
DKS Co. Ltd. Provides Consolidated Earnings Guidance for the Half Year and Full Year of Fiscal Year Ending March 31, 2023	22-08-12	CI
Tranche Update on DKS Co. Ltd.'s Equity Buyback Plan announced on June 24, 2022.	22-08-03	CI
DKS Co. Ltd. announces an Equity Buyback for 850,000 shares, representing 8.35% for ¥1,500 million.	22-06-24	CI
DKS Co. Ltd. authorizes a Buyback Plan.	22-06-23	CI
DKS Sees FY22 Attributable Profit Fall 3%	22-06-07	MT
DKS Co. Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023	22-06-06	CI
DKS Co. Ltd. Declares Dividend for the Fiscal Year Ended March 31, 2022, Payable on June 27, 2022; Provides Dividend Guidance for the Second Quarter of the Fiscal Year Ending March 31, 2023	22-06-06	CI
DKS Co. Ltd. Provides Consolidated Financial Guidance for the Half Year and Full Year for the Fiscal Year Ending March 31, 2023	22-06-06	CI
Advantest : Nikkei drops as yen firms on dismal U.S. economic data; Advantest slumps	20-07-30	RE
DKS Co. Ltd. announces an Equity Buyback for 164 shares.	18-10-31	CI

Chart DKS Co. Ltd.

Duration

Period

More charts

Company Profile

DKS Co. Ltd. is engaged in the manufacture and sale of surfactants, functional materials and electronic device materials. The Company operates in five business segments. The Surfactant segment is engaged in the manufacture and sale of nonionic surfactants, anionic surfactants, cationic surfactants and amphoteric surfactants. The Amenity Materials segment is engaged in the manufacture and sale of sucrose fatty acid esters, cellulose-based polymer materials, vinyl-based polymer materials and health supplements. The Urethane Materials segment is engaged in the manufacture and sale of polyether polyols, urethane prepolymers and urethane systems. The Functional Materials segment is engaged in the manufacture and sale of materials for photocurable resins, aqueous urethane resins, flame retardants, amide-based lubricants. The Electronic Device Materials segment is engaged in the manufacture and sale of conductive pastes for electronic components and pellets for injection molding.

Sector

Commodity Chemicals

Calendar

2024-07-24 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for DKS Co. Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3,800 JPY

Average target price

4,900 JPY

Spread / Average Target

+28.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

	1st Jan change	Capi.
DKS CO. LTD.	+93.78%	231M
AIR LIQUIDE	-0.52%	98.49B
SABIC	-10.90%	58.77B
PT CHANDRA ASRI PACIFIC TBK	+63.33%	45.23B
WANHUA CHEMICAL GROUP CO., LTD.	+12.56%	37.42B
LYONDELLBASELL INDUSTRIES N.V.	-1.62%	30.46B
WESTLAKE CORPORATION	+7.05%	19.26B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+11.98%	16.67B
HENGLI PETROCHEMICAL CO.,LTD.	+6.45%	13.6B
RONGSHENG PETROCHEMICAL CO., LTD.	-6.76%	12.73B

Other Commodity Chemicals

DKS Co. Ltd.

Equities

4461

JP3475000000

Commodity Chemicals

DKS Co. Ltd. acquired Biococoon Laboratories, Inc. and Ikeda Yakusou Co., Ltd.

EPS Revisions